Great Lakes Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History

Great Lakes Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$41.92 - $58.18 $16.3 Million - $22.6 Million	-389,071 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$52.06 - $61.27 $119,113 - $140,185	-2,288 Reduced 0.58%	389,071 $21.4 Million
Q1 2021 May 03, 2021	BUY	$44.23 - $57.5 $1.09 Million - $1.42 Million	24,660 Added 6.72%	391,359 $20.2 Million
Q4 2020 Feb 09, 2021	SELL	$33.21 - $46.54 $670,543 - $939,689	-20,191 Reduced 5.22%	366,699 $15.9 Million
Q3 2020 Nov 04, 2020	BUY	$33.87 - $55.93 $2.13 Million - $3.52 Million	62,927 Added 19.42%	386,890 $13.5 Million
Q2 2020 Aug 07, 2020	BUY	$34.45 - $53.48 $11.2 Million - $17.3 Million	323,963 New	323,963 $17.3 Million

241

58.3M

270K

332K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.64B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.